HB 4721

West Virginia House of Delegates bill in Session 2026RS.

Status: in_committee. Latest action: January 22, 2026.

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration.

Bill ID WV-2026RS-HB-4721
Session 2026RS
Status in_committee
Committee Health and Human Resources
House of Delegates in_committee 2026-01-22
Summary

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Sponsor
Rick Hillenbrand
Official Source Back to Bills
Actions Timeline
Date Event Detail
0000-00-00 Introduced Bill introduced
2026-01-22 Status in_committee
2026-01-22 Latest Action H To House Health and Human Resources 01/22/26
More Bills From This Sponsor
HB 5686
Relating to the timing of payments of annually required deposit into an eligible recipient’s Hope Scholarship account
enacted • House of Delegates
HB 4625
Relating to quit claim deeds
enacted • House of Delegates
HB 5437
Creating the Vape Safety Act
enacted • House of Delegates
HB 4452
To remove Mortmain restrictions on religious organizations
enacted • House of Delegates
HB 4869
Establish narrow, clearly bounded guaranteed-issue rights for Medicare Supplement policies in West Virginia.
enacted • House of Delegates
HB 5022
Relating to expanding the programs to be included in the annual capitation rate review.
enacted • House of Delegates